Literature DB >> 28797978

Correlation of Circulating T Lymphocytes and Intracranial Hypertension in Intracerebral Hemorrhage.

Wanqiang Su1, Chuang Gao2, Peng Wang2, Jinhao Huang2, Yu Qian2, Linyue Guo2, Jianning Zhang3, Rongcai Jiang4.   

Abstract

BACKGROUND: The close correlation between intracerebral pressure (ICP) and immunologic responses has been well described, but the role of T lymphocytes in this process remains unknown. This study targeted the relationship of circulating T lymphocytes and ICP in patients with intracerebral hemorrhage (ICH).
METHODS: Between October 2015 and October 2016, consecutive patients age 18-65 years with ICH were enrolled. ICP values were recorded hourly for 5 days, and the screened patients were divided into 2 groups based on ICP: the elevated ICP group (ICP >20 mmHg) and normal ICP group (ICP ≤20 mmHg). Peripheral blood was collected on admission and T lymphocyte subpopulations were analyzed by flow cytometry. Glasgow Coma Scale score on admission and Glasgow Outcome Scale (GOS) score at 30 days after ICH were analyzed.
RESULTS: A total of 44 patients were enrolled, including 18 patients in the elevated ICP group and 26 in the normal ICP group. Both CD3+ and CD4+ T lymphocyte counts were higher in the elevated ICP group (P = 0.004 and 0.000, respectively). The CD8+ T lymphocyte count was not significantly different between the 2 groups (P = 0.751). There were correlation trends between the maximum ICP value and CD3+ lymphocyte count (P = 0.003), CD4+ T lymphocyte count (P = 0.000), and the CD4+/CD8+ T lymphocyte ratio (P = 0.000). The area under the curve (AUC) of CD4+/CD8+ T lymphocyte ratio was the largest among them (P = 0.011 and 0.033), with a significant cutoff value and good specificity and sensitivity. There was a close correlation between the CD4+/CD8+ T lymphocyte ratio and the 30-day GOS score (P = 0.003, AUC = 0.812).
CONCLUSIONS: The CD4+/CD8+ T lymphocyte ratio may be a valuable indicator for predicting postoperative ICP and the short-term prognosis after ICH.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Hypertensive intracerebral hemorrhage; Indicator; Intracranial pressure; Ratio; T lymphocytes

Mesh:

Year:  2017        PMID: 28797978     DOI: 10.1016/j.wneu.2017.07.179

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Intracerebral Hemorrhage Induces Inflammatory Gene Expression in Peripheral Blood: Global Transcriptional Profiling in Intracerebral Hemorrhage Patients.

Authors:  Kyle B Walsh; Xiang Zhang; Xiaoting Zhu; Eric Wohleb; Daniel Woo; Long Lu; Opeolu Adeoye
Journal:  DNA Cell Biol       Date:  2019-05-22       Impact factor: 3.311

2.  Intracranial Hypertension After Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis of Prevalence and Mortality Rate.

Authors:  Daniel Agustín Godoy; Rafael A Núñez-Patiño; Andres Zorrilla-Vaca; Wendy C Ziai; J Claude Hemphill
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

3.  Anti-inflammatory genes in PBMCs post-spontaneous intracerebral hemorrhage.

Authors:  Doan Nguyen; Vi Tran; Alireza Shirazian; Cruz Velasco-Gonzalez; Ifeanyi Iwuchukwu
Journal:  Transl Neurosci       Date:  2021-01-27       Impact factor: 1.757

4.  Screening and identification of biomarkers associated with the immune infiltration of intracerebral hemorrhage.

Authors:  Hao Guo; Yanjun Zhang; Zhanfei Hu; Li Wang; Hongyin Du
Journal:  J Clin Lab Anal       Date:  2022-03-22       Impact factor: 3.124

Review 5.  When the Blood Hits Your Brain: The Neurotoxicity of Extravasated Blood.

Authors:  Jesse A Stokum; Gregory J Cannarsa; Aaron P Wessell; Phelan Shea; Nicole Wenger; J Marc Simard
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

6.  Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage.

Authors:  Marc Durocher; Bradley P Ander; Glen Jickling; Farah Hamade; Heather Hull; Bodie Knepp; Da Zhi Liu; Xinhua Zhan; Anh Tran; Xiyuan Cheng; Kwan Ng; Alan Yee; Frank R Sharp; Boryana Stamova
Journal:  J Neuroinflammation       Date:  2019-03-05       Impact factor: 8.322

Review 7.  Nanomedicine-based immunotherapy for central nervous system disorders.

Authors:  Sumaira Hanif; Pir Muhammad; Rose Chesworth; Fawad Ur Rehman; Rong-Jun Qian; Meng Zheng; Bing-Yang Shi
Journal:  Acta Pharmacol Sin       Date:  2020-05-28       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.